20.51
-0.03 (-0.15%)
| Previous Close | 20.54 |
| Volume | 212,892 |
| Price / Earnings (Forward) | 29.15 |
| Price / Sales | 4.22 |
| Price / Book | 3.33 |
| 52 Weeks Range | |
| TTM Dividend Yield | 0.30% |
| Profit Margin | 11.16% |
| Operating Margin (TTM) | 13.97% |
| Diluted EPS (TTM) | 0.540 |
| Quarterly Revenue Growth (YOY) | 8.70% |
| Quarterly Earnings Growth (YOY) | 40.90% |
| Total Debt/Equity (MRQ) | 27.86% |
| Current Ratio (MRQ) | 1.83 |
| Operating Cash Flow (TTM) | 184.02 M |
| Levered Free Cash Flow (TTM) | -113.47 M |
| Return on Assets (TTM) | 4.88% |
| Return on Equity (TTM) | 9.14% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Mixed | |
| Stock | Stevanato Group S.p.A. | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -1.0 |
| Technical Moving Averages | 3.5 |
| Technical Oscillators | -2.0 |
| Average | 0.14 |
|
Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Mid Growth |
| % Held by Insiders | 1.68% |
| % Held by Institutions | 112.67% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Nicholas Company, Inc. | 30 Jun 2026 | 743,799 |
No data within this time range.
No data within this time range.
| TTM Dividend Yield | 0.30% |
| 4Y Average Dividend Yield | 0.19% |
| Payout Ratio | 11.52% |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 04 Jun 2024 | 10 Apr 2024 | 15 Jul 2024 | 0.0573 Cash |
| 07 Jun 2023 | 05 Apr 2023 | 17 Jul 2023 | 0.0577 Cash |
| 13 Jun 2022 | 11 Apr 2022 | 13 Jul 2022 | 0.0546 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2024 | 0.057 | 1 | 0.26 |
| 2023 | 0.058 | 1 | 0.21 |
| 2022 | 0.055 | 1 | 0.30 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |